Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042354
Status:
COMPLETED
Last Update Posted:
2015-03-05
First Post:
2002-07-26
Brief Title:
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia AML Patients
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
CLO222
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Monitor
Old Organization:
Genzyme Corporation